About this trial
This is a mixed-methods program evaluation from a health systems and policy perspective, involving (i) stakeholder analysis, (ii) policy-implementation gap analysis, and (iii) comparative country case studies. This study aims to understand how national oxygen strategies achieve impact at national, and subnational level, across country contexts, at what cost.
The the investigators seek to:
1. Involve policymakers, implementers (including private sector), and medical oxygen users in identifying challenges and understanding potential solutions to medical oxygen access; 2. Generate new data on how medical oxygen systems work and can be improved from multiple perspectives; 3. Draw lessons on medical oxygen that can directly inform national and global practice and policy.
This study will be conducted in 6 of the 9 countries participating in the Clinton Health Access Initiative (CHAI) led Medical Oxygen Implementation (MOXY) program (Uganda, Nigeria, Rwanda, Liberia, Lao PDR, Cambodia).
Key informants will be selected representing government, non-governmental agencies, professional associations, private sector, and civil society. This study will be completed over 4 years, with timelines varying between country study sites.
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- No intervention
Treatment groups
Sponsors and collaborators
Murdoch Childrens Research Institute
Lead sponsor
University of Ibadan
Collaborator
University of Health Sciences, Lao People's Democratic Republic (PDR)
Collaborator
University of Health Sciences, Cambodia
Collaborator
Makerere University
Collaborator
Ministry of Health, Liberia
Collaborator
Ministry of Health, Rwanda
Collaborator
Karolinska Institutet
Collaborator